NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma, first-line treatment with interferon (IFN)-alpha plus sunitinib or bevacizumab has “clinically relevant and statistically significant” survival…
NEW YORK (Reuters Health) – The results of a 30-year study indicate that intensive glucose control can substantially reduce the rates of retinopathy, nephropathy, and cardiovascular disease in…
NEW YORK (Reuters Health) – In patients with pulmonary thromboemboli, the presence of a mobile right cardiac thrombus (MRCT) is strongly linked to death, new research shows. Although…
Robert Shorr, Ph.D, D.I.C, Chief Executive Officer of Cornerstone Pharmaceuticals, talks about his company’s approach to the treatment of cancer by targeting and exploiting specific metabolic pathways with…
NEW YORK (Reuters Health) – New research indicates that anemia, regardless of comorbid disease, is a risk factor for death in very elderly individuals. In the study, incident…
Dustyn Baker, MD, from the University of Chicago, discusses the Chicago Breathe Project, and explains the differences between the CFC inhalers and the newer HFA inhalers. To learn…
Valerie Press, MD, a Research Fellow in the Hospitalist Program at the University of Chicago, provides step-by-step instructions on how to use the HFA inhaler and the Diskus…
NEW YORK (Reuters Health) – In a study of a busy coronary care unit in Kuwait, 41.1% of patients treated with unfractionated heparin for 6 hours had a…
NEW YORK (Reuters Health) – Temperature lowering, either by pharmacologic or physical means, does not improve stroke outcomes, according to a review of trial data. Prior research has…
NEW YORK (Reuters Health) – Compared with a strategy of optimal medical therapy alone for treatment of stable coronary artery disease (CAD), the addition of percutaneous coronary intervention…
